Search Results for: Linee guida sulle cure palliative nei pazienti affetti da cancro

Via alla seconda edizione del Barometro del patient engament

Studio, obiettivo sarà indirizzare da subito questi pazienti verso altre cure

Consentirà di personalizzare cure sin dal momento della diagnosi

Studio su Nature Genetics, possibile scegliere subito altre cure

Nel 66% dei pazienti fremanezumab funziona anche a lungo termine

In campo squadre dei Centri oncoematologia pediatrica d’Italia

Stomaco – L’agopuntura si è dimostrata efficace nel recupero dei pazienti con gastrectomia: uno studio sul post-operatorio nel tumore allo stomaco.

Objectives
Despite palliative care (PC) potentially improving quality of life, only a tiny proportion of patients with heart failure (HF) are receiving PC. Globally, PC for HF patients faces several challenges; however, a systematic assessment of the barriers and facilitators to PC of patients suffering from HF is lacking. We aimed to identify barriers and facilitators to offering PC to HF patients.

Design
The mixed-methods systematic review was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement.

Data sources
PubMed, CINAHL, MEDLINE, PsycINFO, Web of Science were searched from onset of literature database to 24 March 2025.

Eligibility criteria
We included both qualitative studies and quantitative studies addressing barriers and facilitators to offering PC to patients with HF reported by healthcare providers, patients, family members and caregivers.

Data extraction and synthesis
Data extraction was done independently by two reviewers, and quality assessment was completed using the mixed-methods appraisal tool. The Capabilities-Opportunities-Motivations-Behaviour (COM-B) model and the Theoretical Domain Framework (TDF) were used to identify potential barriers and facilitators.

Results
48 studies were included out of 4168. 289 items related to barriers and 88 items related to facilitators were categorised into 72 themes. These themes were found to align with at least one of the 14 TDF domains and the COM-B model. ‘Environmental context and resources’ (eg, lack of time, human, facilities and equipment resources; 77.2% of barriers vs 22.8% of facilitators), ‘knowledge’ (eg, insufficient awareness and knowledge of PC and/or needs; 91.8% of barriers vs 8.2% of facilitators) and “‘social influences’ (eg, limited communication and collaboration between healthcare professionals; 58.7% of barriers vs 41.3% of facilitators) were the three TDF domains that encoded the largest amount of data.

Conclusions
This review identified key barriers to PC for HF patients, primarily involving resource limitations, knowledge gaps and poor interdisciplinary collaboration. Findings highlight the need for targeted interventions addressing systemic and knowledge-related challenges.

PROSPERO registration number
CRD42023484807.

37 studi clinici attivi, 75.000 pazienti coinvolti nella ricerca

39 quelle firmate dagli oncologi Aiom. Il caso delle terapie neoadiuvanti

Efficace su recidive per pazienti pretrattati, ok da Aifa alla rimborsabilità

Dagli esperti del Bambino Gesù, niente sole fino ai 6 mesi

Boom di studi scientifici sul tema, + 5.000% in 10 anni

‘Oltre 25 miliardi per cure non garantite, non è fuga da Ssn’